{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:37:48Z","timestamp":1784216268180,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14CIII\/00005"],"award-info":[{"award-number":["PI14CIII\/00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17CIII\/00013"],"award-info":[{"award-number":["PI17CIII\/00013"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008545","name":"Asociaci\u00f3n Pablo Ugarte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.omto.2020.08.006","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:31:27Z","timestamp":1597411887000},"page":"525-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Ana","family":"G\u00f3mez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sard\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cejalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Judith","family":"Peris\u00e9-Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2020.08.006_bib1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omto.2020.08.006_bib2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.gt.3302880","article-title":"Evaluation of T\u00a0cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies","volume":"14","author":"Ong","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib3","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/gt.2008.40","article-title":"Taming the Trojan horse: optimizing dynamic carrier cell\/oncolytic virus systems for cancer biotherapy","volume":"15","author":"Power","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.moh.0000245698.62511.3d","article-title":"Stem cell homing","volume":"13","author":"Chute","year":"2006","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.omto.2020.08.006_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/OV.S66010","article-title":"Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology","volume":"4","author":"Ram\u00edrez","year":"2015","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.omto.2020.08.006_bib6","first-page":"387","article-title":"Oncolytic virotherapy for neuroblastoma","volume":"10","author":"Ram\u00edrez","year":"2010","journal-title":"Discov. Med."},{"key":"10.1016\/j.omto.2020.08.006_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.mt.6300239","article-title":"Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway","volume":"15","author":"Cascallo","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/cgt.2010.4","article-title":"Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study","volume":"17","author":"Garc\u00eda-Castro","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2015.11.036","article-title":"Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells","volume":"371","author":"Melen","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omto.2020.08.006_bib10","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1200\/JCO.2018.36.15_suppl.10543","article-title":"First-in-child trial of Celyvir (Autologous mesenchymal stem cells carrying the oncolytic virus ICOVIR-5) in patients with relapsed and refractory pediatric solid tumors","volume":"36","author":"Ramirez","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omto.2020.08.006_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2020.08.006_bib12","doi-asserted-by":"crossref","first-page":"308ps21","DOI":"10.1126\/scitranslmed.aaa9116","article-title":"Companion animals: Translational scientist\u2019s new best friends","volume":"7","author":"Kol","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omto.2020.08.006_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-10-3","article-title":"Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients","volume":"10","author":"Patil","year":"2012","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omto.2020.08.006_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejca.2003.11.031","article-title":"Spontaneous and genetically engineered animal models; use in preclinical cancer drug development","volume":"40","author":"Hansen","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omto.2020.08.006_bib15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/mt.2010.79","article-title":"Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth","volume":"18","author":"Guedan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib16","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1158\/0008-5472.CAN-17-3754","article-title":"Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy","volume":"78","author":"Cejalvo","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2020.08.006_bib17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/mt.2015.125","article-title":"Biodistribution Analysis of Oncolytic Adenoviruses in Patient Autopsy Samples Reveals Vascular Transduction of Noninjected Tumors and Tissues","volume":"23","author":"Koski","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib18","first-page":"137","article-title":"International histological classification of tumours of domestic animals: Introduction","volume":"53","author":"Beveridge","year":"1976","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.omto.2020.08.006_bib19","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/2168479017738979","article-title":"A Comparative Safety Profile Assessment of Oncolytic Virus Therapy Based on Clinical Trials","volume":"52","author":"Matsuda","year":"2018","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.omto.2020.08.006_bib20","doi-asserted-by":"crossref","first-page":"e47472","DOI":"10.1371\/journal.pone.0047472","article-title":"Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody","volume":"7","author":"Patil","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omto.2020.08.006_bib21","series-title":"In Infectious diseases of the dog and cat","first-page":"1354","author":"Greene","year":"2012"},{"key":"10.1016\/j.omto.2020.08.006_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cvsm.2008.02.006","article-title":"Canine Adenoviruses and Herpesvirus.","volume":"38","author":"Decaro","year":"2008","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.omto.2020.08.006_bib23","series-title":"Jubb, Kennedy, and Palmer\u2019s pathology of domestic animals","article-title":"Infectious diseases of the respiratory system","author":"Maxie","year":"2015"},{"key":"10.1016\/j.omto.2020.08.006_bib24","first-page":"601","article-title":"Administration of a conditionally replicative oncolytic canine adenovirus in normal dogs","volume":"21","author":"Smith","year":"2006","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.omto.2020.08.006_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/mt.2014.7","article-title":"A pRb-responsive, RGD-modified, and hyaluronidase-armed canine oncolytic adenovirus for application in veterinary oncology","volume":"22","author":"Laborda","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2020.08.006_bib26","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","article-title":"RB and cell cycle progression","volume":"25","author":"Giacinti","year":"2006","journal-title":"Oncogene"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770520301236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:35:36Z","timestamp":1778880936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770520301236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":26,"alternative-id":["S2372770520301236"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2020.08.006","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2020.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}